Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
26 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Companies
Top Ten Companies //
Browse A - Z of companies
Merck KGaA
(Merck)
Merck
(Merck KGaA)
Pfizer
Roche
Novartis
GlaxoSmithKline
(GSK)
GSK
(GlaxoSmithKline)
Bristol-Myers Squibb
Lilly
Bayer
Browse the A - Z of Companies
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
N
Nabi Biopharmaceuticals
Nabriva Therapeutics
Nanjing MeiRue Pharma
Nanjing MeiRui Pharma
Nanobiotix
Nanolek
NanoViricides
Napo Pharmaceuticals
Napp Pharmaceuticals
Natco Pharma
Natur Produkt
Navamedic
Navidea Biopharmaceuticals
NDA Group
Nektar Therapeutics
NeoPharm
Neopharma
Neoprobe
NeoStem
Neotope Biosciences
Neovacs
Nepentes
NeRReTherapeutics
Nesher Pharma
Nestle
NeuClone
Neuland Laboratories
Neuralstem
Neurim Pharmaceuticals
Neurimmune
Neurocrine Biosciences
NeuroNova
NeurOp
NeuroSearch
NeuroVive
Neviah Genomics
NewBridge Pharmaceuticals
Newport Pharma
Newron Pharma
NewVac
NexMed Pharma
NextWave Pharmaceuticals
NGM Biopharmaceuticals
Niacet
Nichi-Iko
NicOx
Nippon Chemiphar
Nippon Kayaku
Nippon Shinyaku
Nipro
Niro
Nitto Denko
Nobelpharma
Nordic Bioscience
nORDIC COCHRANE CENTRE
Nordic Group
Nordic Pharma
Nordion
Norgine
Northwest Biotherapeutics
Norton Healthcare
NovaBay Pharmaceutical
NovaDel Pharma
Novagali
NovAliX
NovaMed Pharma
NovaMedica
Novartis
Novasep
Novast Laboratories
Novatrend Medicament
Novavax
Novelos Therapeutics
Noven Pharmaceuticals
NovImmune
Novo A/S
Novo Nordisk
Novogen
Novozymes
NP Pharm
NPS Pharmaceuticals
Numab
NuPathe
Nuron Biotech
Nutra Pharma
Nuvilex
Nuvo Research
Nycomed
Nycomed US
Nymox Pharma
Nyuvak
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth